Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Cara Therapeutics (NASDAQ: CARA)

Last Updated: Dec-06-2016 20:14:07

Premium Research

Cara Therapeutics (NASDAQ: CARA) Profile

Prior Close$9.73
Market Cap$0.27 B
PE Ratio
Cara Therapeutics Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics Inc. is based in Shelton United States.
SymbolCompanyMarket cap
GILDGilead Sciences Inc$95.33 B
CELGCelgene Corp$90.36 B
REGNRegeneron Pharmaceutical$39 B
BXLTBaxalta Incorporated Common Sto$31.46 B
ALIOFActelion Ltd$22.5 B
INCYIncyte Corporation$19.74 B
ILMNIllumina Inc$18.79 B
VRTXVertex Pharmaceutic$18.74 B
BMRNBiomarin Pharmaceut$14.18 B
SGENSeattle Genetics Inc$9.38 B

CARA Earnings

1st Quarter Earnings$-0.42 (2016-11-03)
2nd Quarter Earnings$-0.48 (2016-08-04)
3rd Quarter Earnings$-0.39 (2016-05-05)
4th Quarter Earnings$-0.35 (2016-03-10)
PE Ratio0
EPS Growth-79.2%
Recent Earnings$-0.42
Annual EPS$-1.41
Market Capitalization$0.27 B
Insider Shareholder %0.077%
Annual Revenue$0 B
Number of Shares Outstanding27,280 Shares
Institutional Shareholder %46.08%
Annual Net Income$-0.04B
TTM Net Profit Margin$-49822.22
One Year Return-35.57%
Three Year Return-20.62%
Five Year Return-24.24%
Five Year Revenue Growth0%
Five Year Earnings Growth0%
Five Year Dividend Growth0%
Last Quarter EPS$-0.48
Annual EPS$-1.41
Annual Dividend$0
Annual Dividend Yield0%
Change in EPS YTD-79.199997%
PE Ratio
Recent Earnings$-0.42
Dividends per Share$
Stock Split Ratio

CARA Key Stats

Last Price$9.78
Net Change$0.05 (0.51%)
Ask Price$9.9
Open Price$9.73
Previous Close Price$9.73
High Price$9.9
Low Price$9.49
Number of Trades2,550
Fifty Two Week High$17.69 (2016-01-06)
Fifty Two Week Low$4.26 (2016-02-26)
Average Daily Volume892,216
Share Outstanding27,280 Shares
Total Dividend Payout$0/yr
Dividend Yield0%